𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-γ

✍ Scribed by Janet F. Piskurich; Carolyn A. Gilbert; Brittany D. Ashley; Mojun Zhao; Han Chen; Jian Wu; Sophia C. Bolick; Kenneth L. Wright


Book ID
116755626
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
358 KB
Volume
43
Category
Article
ISSN
0161-5890

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Regulation of MHC class II expression in
✍ Yukio Takamura; Hideyuki Ikeda; Takayuki Kanaseki; Minoru Toyota; Takashi Tokino 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

## Abstract We first classified 12 malignant glioma cell lines into three different groups (types 1–3) with respect to major histocompatibility complex (MHC) class II expression and analyzed each group based on the different expression status of the class II transactivator (CIITA) gene. Glioma type

Regulation of the expression of MHC clas
✍ Aichun Liu; Masuhiro Takahashi; Ken Toba; Zhiyin Zheng; Shigeo Hashimoto; Kohji 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

In order to develop an effective immunotherapy for hematological malignancies, we investigated the applicability of class II transactivator (CIITA), which had been demonstrated to regulate the expression of MHC class II (MHC-II) by assembling the transcription factors of MHC-II molecules, for immuno

Malignant glioma cells use MHC class II
✍ Jeanne M. Soos; Jeffrey I. Krieger; Olaf Stüve; Chelsea L. King; Juan Carlos Pat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Malignant gliomas (MGs), lethal human central nervous system (CNS) neoplasms, contain tumor infiltrating lymphocytes (TIL). Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4^+^ T cells, deficienci

Lack of ifn-γ-mediated induction of the
✍ Nienke van der Stoep; Paula Biesta; Edwin Quinten; Peter J. van den Elsen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 401 KB

## Abstract Downregulation of major histocompatibility complex (MHC) molecules by tumor cells impairs cellular immune recognition and contributes to inefficient cell‐mediated tumor eradication. Low or lack of expression of MHC molecules is frequently observed in early developmental or embryonically